+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2013-12-13Number of Pages: 120

Equine Healthcare Market (Diagnostic Product Type – Equine Pregnancy and Gestation Diagnostic Products and Equine Genotyping Analysis Products; Therapeutic Product Type - Equine Vaccines Market, Equine Antibacterials Market, Equine Antivirals Market, Equine Antiprotozoals Market, Equine Dopamine Agonists Market, Equine Anti-inflammatory Drugs Market, and Equine Laxatives Market; Equine Supplement Products Type - Equine Performance Supplements and Equine Protection Products) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

Global Equine Healthcare Market: Overview

The global equestrian market is a growing industry that includes competitive and leisure riding, horse racing, and it also supports the multifarious secondary markets across the globe, the equine healthcare market being one of them. Equine health is the veterinary services which are proposed for the treatment of horses to improve their quality of life, upsurge their lifecycle, and improve the quality of animal food products. Equine therapeutic products, equine diagnostic products, and equine supplement products are the three chief product types under the global equine healthcare market. Equine diagnostic products help in the detection of antibodies, viruses, and bacteria; equine therapeutic products comprise vaccination that aids in the treatment of any disease situation; and equine supplement products aid in sustaining a specific obligation of supplements.

The players are attracted by a high return on investments (ROI) which is leading to market enlargement. Moreover, the investments by various regions in horse racing are propelling the growth of the global equine healthcare market. However, the easy availability of substitutes for gambling such as online gambling and the decreasing population of equestrian is restraining the growth of the market. The evolving sub segments in the market are likely to provide growth opportunities to manufacturers. The global equine healthcare market is a developing field of pharmaceuticals. The global market is however facing challenges owing to the stringent regulations imposed by governments. Nevertheless, these regulations are deliberately allocated and more importance is given on the marketable policies available for the products. This industry witnesses high competition owing to many players present for the similar product. The market dynamics exhibit that the influence of drivers is comparatively more on the market as compared to the inhibitors.

The global equine healthcare market is likely to exhibit minute 1.20% CAGR from 2013 to 2019. The market was worth US$26.6 bn in 2012 and is likely to fall to a valuation of US$24.5 bn by 2019.

Genotype Analyzers to Exhibit Positive Signs and Grow Significantly

Genotype analyzers or breed quality analyzers are an important part of the equine diagnostics product segment in the global equine healthcare market. This particular segment is likely to expand at a 15% CAGR during the forecast period. This growth can be attributed to the rising sales of analysis kits across the globe. The market is segmented into therapeutic, supplement, and diagnostic products. Equine diagnostic products is expected to lead the market in the near future.

North America Market to be Adversely Effected as Horse Owners Close down Business

Going till 2019, almost 50% of the horse-owners in North American showed deteriorating interests in joining the equine events, shows, and racing. The horse-owners further stated that they are expected to limit equestrian operations only till the ‘breeding’ sub-set of the value-chain to capitalize on the return on investments and also export high quality breed of horses to specific destinations such as China. Thus, the North America equine healthcare market is likely to decay by -1.0% until 2019.

The companies in the market are Equine Orthotics and Prosthetics, Equine Health U.K., Zoetis (Pfizer Animal Health), Elanco Animal Heath, Affymetrix, Boehringer Ingelheim Vetmedica, and Merck Animal Health.

Table of Contents
 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions
 
Chapter 2 Executive Summary
 
Chapter 3 Global Equine Healthcare Market Overview
3.1 Definition - Equine Healthcare
3.2 Significance of Equestrian Industry and Equine Healthcare
3.3 Drivers
      3.3.1 High ROI Attracts Market Participants and Expands the Market
      3.3.2 Multiple Support or Secondary Markets Drive Growth
      3.3.3 Newer Geographical Regions Investing in Horse Racing and Betting
      3.3.4 Initiatives by Equine Healthcare Organizations and Market Participants
3.4 Restraints
      3.4.1 Declining global equine population
      3.4.2 Alternative Forms of Gambling such as ‘Online Betting/Gaming’ on the fore of ‘Legal’ Status
3.5 Opportunities
      3.5.1 Equine Healthcare Sub-Segment Markets - Opportunity Matrix
      3.5.2 Asia-Pacific Market - Niche Opportunity
3.6 Porter’s Five Forces Analysis
      3.6.1 Bargaining Power of Suppliers
      3.6.2 Bargaining Power of Buyers
      3.6.3 Threat of New Entrants
      3.6.4 Threat of Substitutes
      3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis: Global Equine Healthcare Market, by Geography
 
Chapter 4 Global Equine Diagnostic Products Market, by Type, 2011 - 2019 (USD Million)
4.1 Equine Pregnancy and Gestation Diagnostic Products Market
      4.1.1 Equine UltraSound Devices Market
              4.1.1.1 Global Equine UltraSound Devices Market, Value, 2011 - 2019 (USD Million)
      4.1.2 Equine Urine Test Kits Market
              4.1.2.1 Global Equine Urine Test Kits Market, Value, 2011 - 2019 (USD Million)
4.2 Equine Genotyping Analysis Products Market
      4.2.1 Global Equine Genotyping Analysis Products Market, Value, 2011 - 2019 (USD Million)
      4.2.2 Breed Quality Analyzers/Genotype Analyzers Kits Market
      4.2.3 Genetic Disease Identification Products/Semen Quality Analyzers Market
 
Chapter 5 Global Equine Therapeutic Products Market, by Type, 2011 - 2019 (USD Million)
5.1 Equine Vaccines Market
      5.1.1 Global Equine Vaccines Market, Value, 2011 - 2019 (USD Million)
5.2 Equine Therapeutic Products Market
      5.2.1 Equine Antibacterials Market
              5.2.1.1 Global Equine Antibacterials Market, Value, 2011 - 2019 (USD Million)
      5.2.2 Equine Antivirals Market
              5.2.2.1 Global Equine Antivirals Market, Value, 2011 - 2019 (USD Million)
      5.2.3 Equine Antiprotozoals / Dewormers Market
              5.2.3.1 Global Equine Antiprotozoals/Dewormers Market, Value, 2011 - 2019 (USD Million)
      5.2.4 Equine Dopamine Agonists Market
              5.2.4.1 Global Equine Dopamine Agonists Market, Value, 2011 - 2019 (USD Million)
      5.2.5 Equine Anti-inflammatory Drugs Market
              5.2.5.1 Global Equine Anti-inflammatory Drugs Market, Value, 2011 - 2019 (USD Million)
      5.2.6 Equine Laxatives Market
              5.2.6.1 Global Equine Laxatives Market, Value, 2011 - 2019 (USD Million)
 
Chapter 6 Global Equine Supplement Products Market, by Type, 2011 - 2019 (USD Million)
6.1 Equine Performance Supplements Market
      6.1.1 Global Equine Performance Supplements Market, Value, 2011 - 2019 (USD Million)
      6.1.2 Equine Proteins and Amino Acids Supplements Market
      6.1.3 Equine Vitamin Supplements Market
      6.1.4 Equine Electrolyte Supplements Market
      6.1.5 Other Equine Performance Supplements Market
6.2 Equine Protection Products Market
      6.2.1 Equine Protection Products Market
              6.2.1.1 Global Equine Protection Products Market, Value, 2011 - 2019 (USD Million)
      6.2.2 Equine Prosthetics Market
              6.2.2.1 Global Equine Prosthetics Market, Value (in USD Million)
 
Chapter 7 Global Equine Healthcare Market, by Geography, 2011 - 2019 (USD Million)
7.1 Introduction
      7.1.1 Global Equine Healthcare Market, by Geography, 2011 - 2019 (USD Million)
7.2 North America Equine Healthcare Market: Market Size, 2013 and 2019 (USD Million)
7.3 Europe Equine Healthcare Market: Market Size, 2013 and 2019 (USD Million)
7.4 Asia-Pacific Equine Healthcare Market: Market Size, 2013 and 2019 (USD Million)
7.5 Rest of the World (RoW) Equine Healthcare Market: Market Size, 2013 and 2019 (USD Million)
 
Chapter 8 Company Profiles
8.1 Affymetrix, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Bayer
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Strategic Overview
8.3 Boerhringer Ingelheim Vetmedica, Inc. (BIVI)
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Strategic Overview
8.4 Elanco Animal Health
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Strategic Overview
8.5 Equine Diagnostics
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product/Services Portfolio
      8.5.4 Strategic Overview
8.6 Equine Orthotics and Prosthetics
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Strategic Overview
8.7 Equine Products (UK) Ltd.
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Strategic Overview
8.8 Merck Animal Health
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Strategic Overview
8.9 Purina Mills, LLC
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Strategic Overview
8.10 Signostics Limited
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Strategic Overview
      8.10.5 Recent Developments
8.11 Zoetis, Inc.
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Products/Services Portfolio
      8.11.4 Strategic Overview

List of Figures
 
Fig. 1 Equine Healthcare Market: Market Segmentation
Fig. 2 Global Equine Healthcare Market, By Segments, 2012, Value (USD Million)
Fig. 3 Equine Healthcare: Economic Impact
Fig. 4 Equine Healthcare: Supports Multiple Secondary Markets
Fig. 5 Porter’s Five Forces Analysis for Equine Therapeutic Market
Fig. 6 Market Attractiveness Analysis: Global Equine Healthcare Market, By Geography
Fig. 7 Global Equine Ultrasound Devices Market, Value, 2011 - 2019 (USD Million)
Fig. 8 Global Equine Urine Test Kits Market, Value, 2011 - 2019 (USD Million)
Fig. 9 Global Equine Genotyping Analysis Products Market, Value, 2011 - 2019 (USD Million)
Fig. 10 Global Equine Vaccines Market, Value, 2011 - 2019 (USD Million)
Fig. 11 Global Equine Antibacterials Market, Value, 2011 - 2019 (USD Million)
Fig. 12 Global Equine Antivirals Market, Value, 2011 - 2019 (USD Million)
Fig. 13 Effect of Dewormers Dosage Optimization
Fig. 14 Global Equine Antiprotozoals/Dewormers Market, Value, 2011 - 2019 (USD Million)
Fig. 15 Effect of Cushing’s Disease : Healthy Horse and Horse Suffering From Cushing’s Disease
Fig. 16 Global Equine Dopamine Agonists Market, Value, 2011 - 2019 (USD Million)
Fig. 17 Global Equine Anti-Inflammatory Drugs Market, Value, 2011 - 2019 (USD Million)
Fig. 18 Global Equine Laxatives Market, Value, 2011 - 2019 (USD Million)
Fig. 19 Global Equine Performance Supplements Market, Value, 2011 - 2019 (USD Million)
Fig. 20 Global Equine Protection Products Market, Value, 2011 - 2019 (USD Million)
Fig. 21 Global Equine Prosthetics Market, Value, 2011 - 2019 (USD Million)
Fig. 22 Global Equine Healthcare Market, By Geography, 2011 - 2019 (usd Million)
Fig. 23 Comparative Analysis: Equine Healthcare Market, North America, 2013 and 2019 (Usd Million)
Fig. 24 Comparative Analysis: Equine Healthcare Market, Europe, 2013 and 2019 (Usd Million)
Fig. 25 Comparative Analysis: Equine Healthcare Market, Asia-Pacific, 2013 and 2019 (USD Million)
Fig. 26 Comparative Analysis: Equine Healthcare Market, Row, 2013 and 2019 (USD Million)
Fig. 27 Affymetrix: Annual Sales Revenue, 2010 – 2012 (USD Million)
Fig. 28 Bayer Ag: Annual Sales Revenue, 2011 – 2013 (USD Million)
Fig. 29 Boehringer Ingelheim Vetmedica: Annual Sales Revenue, 2011 – 2013 (USD Million)
Fig. 30 Elanco Animal Health: Annual Sales Revenue, 2011 – 2013 (USD Million)
Fig. 31 Merck Animal Health: Annual Sales Revenue, 2011 – 2013 (USD Million)
Fig. 32 Zoetis, Inc.: Annual Sales Revenue, 2011 – 2013 (USD Million)

List of Tables
 
Table 1 Market Snapshot: Global Equine Healthcare Market
Table 2 Global Equine Diagnostic Products Market, Value, 2011 - 2019 (USD Million)
Table 3 Global Equine Therapeutic Products Market, Value, 2011 - 2019 (USD Million)
Table 4 Global Equine Supplement Products Market, Value, 2011 - 2019 (USD Million)

The global equestrian market is a multi-billion dollar industry that comprises horse racing and betting, leisure and competitive riding and has spawned and supports multifarious secondary markets; the equine healthcare market ranks as the one of the key secondary markets. This report exclusively studies the market for equine healthcare from varied aspects such as, in terms of equine diagnostic products, equine therapeutic products and equine supplement products; and is thus classified into three prime segments namelyequine diagnostic products market, equine therapeutic products market and equine supplement products market. The market size and forecast for the period 2013–2019, in terms of USD million, considering 2012 as the base year has been provided for each segment and sub-segments in the report. The compound annual growth rate (CAGR) for each segment and sub-segments has been provided for the forecast period from 2013–2019.
 
Geographically, the equine healthcare market has been classified into four regions -North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region along with their market growth rate has been highlighted. The market overview section of the report comprises of a qualitative analysis of the market in terms of drivers, restraintsand opportunities, along with market attractiveness analysis.
 
The report concludes with the competitive landscape and company profiles of few market players in this industry, as of 2012. The market players profiled in this report include Elanco Animal Health, Merck Animal Health, Zoetis (Pfizer Animal Health), Boehringer Ingelheim Vetmedica, Bayer Animal Health, Equine Health U.K., Equine Orthotics and Prosthetics, Affymetrix, Equine Diagnostics, Signostics and Purina.
 
The global equine healthcaremarket is segmented as follows:
 
Equine Diagnostic Products Market, by Type
  • Equine Pregnancy and Gestation Diagnostic Products Market
    • Equine UltraSound Devices Market
    • Equine Urine Test Kits Market
  • Equine Genotyping Analysis Products Market
    • Breed Quality Analyzers/Genotype Analyzers Kits Market
    • Genetic Disease Identification Products/Semen Quality Analyzers Market

 

Equine Therapeutic Products Market, by Type

 

  • Equine Vaccines Market
  • Equine Antibacterials Market
  • Equine Antivirals Market
  • Equine Antiprotozoals Market
  • Equine Dopamine Agonists Market
  • Equine Anti-inflammatory Drugs Market
  • Equine Laxatives Market

 

Equine Supplement Products Market, by Type

 

  • Equine Performance Supplements Market
    • Equine Proteins and Amino Acids Supplements Market
    • Equine Vitamin Supplements Market
    • Equine Electrolyte Supplements Market
    • Other Equine Performance Supplements Market
  • Equine Protection Products Market
    • Equine Protection Products Market
    • Equine Prosthetics Market

 

Equine Healthcare Market, by Geography

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


 
 
Back To Top